ETF Managers Group, LLC Talis Biomedical Corp Transaction History

ETF Managers Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $10,329 - $33,293	-7,946 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.17 $5,139 - $8,323	-1,349 Reduced 14.51%	7,946 $32,000
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $10,438 - $21,605	1,734 Added 22.93%	9,295 $56,000
Q2 2021 Aug 16, 2021	SELL	$9.62 - $14.56 $3,030 - $4,586	-315 Reduced 4.0%	7,561 $81,000
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $88,211 - $218,952	7,876 New	7,876 $90,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.9M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.